Literature DB >> 22389749

Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Congqing Wu1, Hong Lu, Lisa A Cassis, Alan Daugherty.   

Abstract

The renin-angiotensin system is an essential regulatory system for blood pressure and fluid homeostasis. Angiotensinogen is the only known precursor of all the peptides generated in this system. While many of the basic understandings of angiotensinogen have come from research efforts to define its role in blood pressure regulation, novel pathophysiological functions of angiotensinogen have been discovered in the last two decades including kidney developmental abnormalities, atherosclerosis, and obesity. Despite the impressive advance in the understanding of angiotensinogen gene structure and protein functions, some fundamental questions remain unanswered. In this short review, we provide contemporary insights into the molecular characteristics of angiotensinogen and its pathophysiological features. In light of the recent progress, we emphasize some newly recognized functional features of angiotensinogen other than its regulation on blood pressure.

Entities:  

Year:  2011        PMID: 22389749      PMCID: PMC3291105          DOI: 10.7156/v4i4p183

Source DB:  PubMed          Journal:  N Am J Med Sci (Boston)        ISSN: 1946-9357


  106 in total

Review 1.  Local renin-angiotensin systems: the unanswered questions.

Authors:  A H Jan Danser
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

2.  Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction.

Authors:  Chia-Ti Tsai; Juey-Jen Hwang; Marylyn D Ritchie; Jason H Moore; Fu-Tien Chiang; Ling-Ping Lai; Kuan-Lih Hsu; Chuen-Den Tseng; Jiunn-Lee Lin; Yung-Zu Tseng
Journal:  Atherosclerosis       Date:  2006-11-21       Impact factor: 5.162

3.  Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.

Authors:  A Fukamizu; S Takahashi; M S Seo; M Tada; K Tanimoto; S Uehara; K Murakami
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

4.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Renin expression at sites of repair in the infarcted rat heart.

Authors:  Y Sun; J Zhang; J Q Zhang; K T Weber
Journal:  J Mol Cell Cardiol       Date:  2001-05       Impact factor: 5.000

6.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Authors:  Hong Lu; Debra L Rateri; David L Feldman; Richard J Charnigo; Akiyoshi Fukamizu; Junji Ishida; Elizabeth G Oesterling; Lisa A Cassis; Alan Daugherty
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

7.  Rescue of angiotensinogen-knockout mice.

Authors:  J Ishida; F Sugiyama; K Tanimoto; K Taniguchi; M Syouji; E Takimoto; H Horiguchi; K Murakami; K i Yagami; A Fukamizu
Journal:  Biochem Biophys Res Commun       Date:  1998-11-27       Impact factor: 3.575

Review 8.  Levels of angiotensin and molecular biology of the tissue renin angiotensin systems.

Authors:  M I Phillips; E A Speakman; B Kimura
Journal:  Regul Pept       Date:  1993-01-22

9.  Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice.

Authors:  Nadheige Lochard; David W Silversides; Jorge P van Kats; Chantal Mercure; Timothy L Reudelhuber
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

10.  Astrocytes synthesize angiotensinogen in brain.

Authors:  R L Stornetta; C L Hawelu-Johnson; P G Guyenet; K R Lynch
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

View more
  27 in total

1.  Structurally distinct polycyclic aromatic hydrocarbons induce differential transcriptional responses in developing zebrafish.

Authors:  Britton C Goodale; Susan C Tilton; Margaret M Corvi; Glenn R Wilson; Derek B Janszen; Kim A Anderson; Katrina M Waters; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-05       Impact factor: 4.219

2.  Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.

Authors:  Xiaofeng Chen; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Congqing Wu; Lisa A Cassis; Alan Daugherty; Hong Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-07       Impact factor: 8.311

3.  Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.

Authors:  Feiming Ye; Ya Wang; Congqing Wu; Deborah A Howatt; Chia-Hua Wu; Anju Balakrishnan; Adam E Mullick; Mark J Graham; A H Jan Danser; Jian'an Wang; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 4.  Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.

Authors:  Seonwook Kim; Venkateswaran Subramanian; Ahmed Abdel-Latif; Sangderk Lee
Journal:  Metab Syndr Relat Disord       Date:  2020-02-20       Impact factor: 1.894

5.  Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.

Authors:  Takamitsu Saigusa; Yujing Dang; Adam E Mullick; Steve T Yeh; Michael R Zile; Catalin F Baicu; P Darwin Bell
Journal:  FASEB J       Date:  2015-09-21       Impact factor: 5.191

6.  Changes of urinary angiotensinogen concentration and its association with urinary proteins in diabetic rats.

Authors:  Zhen Zhuang; Qiong Bai; A Lata; Yaoxian Liang; Danxia Zheng; Yue Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Angiotensinogen Exerts Effects Independent of Angiotensin II.

Authors:  Hong Lu; Congqing Wu; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Xiaofeng Chen; Mingming Zhao; Mark J Graham; Adam E Mullick; Rosanne M Crooke; David L Feldman; Lisa A Cassis; Craig W Vander Kooi; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

8.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

9.  Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.

Authors:  Congqing Wu; Yinchuan Xu; Hong Lu; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Craig W Vander Kooi; Lisa A Cassis; Jian-an Wang; Alan Daugherty
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

Review 10.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.